Vol. I Advocacy Intelligence Established 2022
A publication of Archo Advocacy

Turn patient insight into organizational influence.

Archo helps life sciences teams convert what patients, advocates, and communities truly need into strategy leadership will fund, trust, and use.

Trusted by patient advocacy & engagement teams across life sciences
argenx Insulet Amgen Neurocrine Merck Dexcom Bristol Myers Squibb Otsuka Takeda Alexion
From patient insight to organizational influence

We build enduring businesses around what patients truly need.

Patients, caregivers, advocates, and professional societies see the friction that shapes access, trust, and care decisions. Most life sciences teams hear those signals. Few have a system to convert them into action. Archo does.

i.

Strategic Insight

Decision-ready Advocacy Intelligence, not surface-level feedback.

ii.

Internal Influence

Tools that move findings into funded, leadership-backed action.

iii.

Patient Trust

Engagement that protects and strengthens community credibility.

iv.

Business Impact

Advocacy positioned as an enterprise strategy function.

Advocacy Influence Diagnostic

How much influence does your advocacy function really have?

Answer twenty questions. Discover which of four advocacy archetypes you are today, and the path to the next.

Take the Diagnostic Free. Twenty questions. About five minutes. Your ELAVAY Index emailed instantly.
The Archo Method

Listen. Interpret. Align. Act.

Movement I

Listen

Capture ground-level signal from patients, advocates, and community leaders.

Movement II

Interpret

Translate Advocacy Intelligence into priorities leadership can act on.

Movement III

Align

Connect findings to business priorities, internal teams, and customers.

Movement IV

Act

Move from research to funded action with twelve months of activation support.

One system. Three ways to engage.

Every engagement begins and ends with what patients truly need.

i.

ELAVAY Research

The syndicated platform for Advocacy Intelligence, showing where you lead, where gaps remain, and where to act.

  • Benchmark and disease-state reports
  • Health equity, SDOH, and policy pulse
  • BioAdvocate Benchmark and custom studies
ii.

Advisory & Activation

Strategic counsel that turns intelligence into internal influence before every critical inflection point.

  • Advocacy Intelligence Exchange (AIX)
  • Advoscape ecosystem mapping
  • Twelve months of activation support
iii.

Training & Enablement

Equip teams to engage advocacy organizations with credibility, and prove the value of advocacy internally.

  • ACE engagement model and workshops
  • Executive-ready storytelling assets
  • Stakeholder decks and briefing sheets

What sets us apart.

Rigorous research meets lived patient experience, and a willingness to say what others won’t.

Insight to action

Data and insights translated into strategic action leadership will fund, trust, and use. Not another report that sits on a shelf.

Expertise and experience

Industry strategy and personal patient experience in one partner. Advocacy fluency you cannot fake.

Fearless partnership

Direct counsel that challenges complacency and protects the trust of the patient community above all.

Why Advocacy Intelligence matters

Advocacy, well integrated, compounds across the organization.

20+

Disease states researched every year, and growing.

Broad cross-therapeutic insight while preserving disease-specific nuance.

2015

Historic benchmarking dating back nearly a decade.

Trend lines that turn resource conversations into evidence-led decisions.

12mo

Activation support after every engagement.

Advisory guidance that helps findings become internal influence.

The Archo Advocate Brief

Dispatches from the field.

Read all issues
Free monograph

Prove the value of advocacy internally.

Translate advocacy work into the language leadership uses to fund priorities and make decisions.

We respect your inbox. Unsubscribe anytime.
In their words

What advocacy leaders say.

Until you know the community’s perception, you really don’t know if you’re effective. The survey provides feedback, and the granular comments offer better insight into their challenges.
Bruce Taylor Leader, Dexcom Patient Advocacy
The ELAVAY Survey was the foundation of our continued defense as the industry’s number-one patient advocacy function for over ten years.
John Hoffman Leader, Janssen Patient Advocacy & Government Affairs
Their work helped our team rethink how we engage and learn from patients.
Healthcare Leader Global Life Sciences Company

Let’s make advocacy essential.

Whether you are exploring research, an advisory session, or team training, we would love to learn more about your goals.